Incidence of carbapenem-resistant Escherichia coli ST2437 of clinical origin harbouring blaOXA-144 gene: a report from India

Author:

Das Bhaskar Jyoti1,Singha K Melson2,Wangkheimayum Jayalaxmi1,Dhar Chanda Debadatta2,Bhattacharjee Amitabha1

Affiliation:

1. Department of Microbiology, Assam University , Silchar, Cachar, Assam 788011 , India

2. Department of Microbiology, Silchar Medical College and Hospital , Silchar, Cachar, Assam 788014 , India

Abstract

Abstract Aims Carbapenem-resistant Escherichia coli has been categorized as a pathogen of critical priority by the World Health Organization as it is highly infectious with high mortality and morbidity rates and widespread transmission potential. Carbapenem resistance is primarily mediated by carbapenemase-encoding genes and, additionally, through intrinsic factors. In India, over the years, carbapenemase-encoding genes have been reported from diverse clinically significant pathogens. The present study identifies E. coli of clinical origin that harbours blaOXA-144. Methods and results The study isolate was obtained from a tertiary referral hospital in northeast India. Carbapenemase production was investigated through culture on chromogenic agar and Rapidec Carba NP test as per manufacturer’s instructions. Susceptibility of the isolate was performed by the Kirby–Bauer disc diffusion method and agar dilution method following CLSI guidelines. PCR targeting carbapenemase-encoding genes was performed, followed by transformation and conjugation experiments. Whole-genome sequencing of the isolate was done through the Illumina sequencing platform and the data were analysed using the Centre for Genomic Epidemiology database. BJD_EC180 is 6 919 180 bp in length and consists of six rRNA operons, 111 tRNA, and 6849 predicted protein-coding sequences. BJD_EC180 belonged to ST2437 and harboured the carbapenemase-encoding gene blaOXA-144 with ISAba1 upstream, along with multiple antibiotic resistance genes conferring clinical resistance towards beta-lactams, aminoglycosides, amphenicols, sulphonamides, tetracyclines, trimethoprim, and rifampin. Conclusions Carbapenem-resistant E. coli harbouring blaOXA-144 associated with insertion sequence pose a serious health threat as their mobilization into carbapenem non-susceptible strains that will contribute to the resistance burden and therefore, needs urgent monitoring.

Funder

DBT

NER

Indian Council of Medical Research

SRF

Publisher

Oxford University Press (OUP)

Reference41 articles.

1. Diversity in Acinetobacter baumannii isolates from paediatric cancer patients in Egypt;Al-Hassan;Clin Microbiol Infect,2013

2. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing;Bankevich;J Comput Biol,2012

3. Carbapenemase-producing organisms: a global scourge;Bonomo;Clin Infect Dis,2018

4. MeDuSa: a multi-draft based scaffolder;Bosi;Bioinformatics,2015

5. Prevalence, genotyping of Escherichia coli and Pseudomonas aeruginosa clinical isolates for Oxacillinase resistance and mapping susceptibility behaviour;Chaudhary,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3